Company
Every investor coverage indicates participated in a round Evonetix Ltd raised.
Companies Evonetix Ltd acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Nick McCooke | Non-Executive Director | Brandon Capital portfolio, Brandon BioCatalyst portfolio |
Stories naming Evonetix Ltd. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Australian genomics spin-out Longas has come out of stealth with technology that extends DNA sequencing read length, backed by the MRCF and its founders, and appoints Solexa's founding chief executive Nick McCooke as CEO.
A university spin-out launches with venture and founder backing, introducing a technology that extends DNA sequencing read lengths, and appointing a new chief executive to commercialise it.